Literature DB >> 28119207

Epitope-dependent mechanisms of CD27 neutralization revealed by X-ray crystallography.

Galina Obmolova1, Alexey Teplyakov2, Thomas J Malia1, Nicole Wunderler1, Deborah Kwok1, Linda Barone1, Raymond Sweet1, Tatiana Ort1, Michael Scully3, Gary L Gilliland4.   

Abstract

CD27 is a T and B cell co-stimulatory protein of the TNF receptor superfamily dependent on the availability of the TNF-like ligand CD70. Two anti-CD27 neutralizing monoclonal antibodies were obtained from mouse hybridoma and subsequently humanized and optimized for binding the target. The two antibodies are similar in terms of their CD27-binding affinity and ability to block NF-κB signaling, however their clearance rates in monkeys are very different. The pharmacokinetics profiles could be epitope dependent. To identify the epitopes, we determined the crystal structure of the ternary complex between CD27 and the Fab fragments of these non-competing antibodies. The structure reveals the binding modes of the antibodies suggesting that their mechanisms of action are distinctly different and provides a possible explanation of the in vivo data.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody; CD27; Crystal structure; Epitope; Mechanism

Mesh:

Substances:

Year:  2017        PMID: 28119207     DOI: 10.1016/j.molimm.2017.01.005

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

1.  Crystal structure of CD27 in complex with a neutralizing noncompeting antibody.

Authors:  Alexey Teplyakov; Galina Obmolova; Thomas J Malia; Gary L Gilliland
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-04-26       Impact factor: 1.056

2.  Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy.

Authors:  Lars Guelen; Thierry O Fischmann; Jerelyn Wong; Smita Mauze; Marco Guadagnoli; Nikolina Bąbała; Jozef Wagenaars; Veronica Juan; David Rosen; Winnie Prosise; Maurice Habraken; Imke Lodewijks; Danling Gu; Judith Stammen-Vogelzangs; Ying Yu; Jeanne Baker; David Lutje Hulsik; Lilian Driessen-Engels; Dan Malashock; Joost Kreijtz; Astrid Bertens; Evert de Vries; Astrid Bovens; Arne Bramer; Yiwei Zhang; Richard Wnek; Sean Troth; Elliot Chartash; Konstantin Dobrenkov; Svetlana Sadekova; Andrea van Elsas; Jason K Cheung; Laurence Fayadat-Dilman; Jannie Borst; Amy M Beebe; Hans Van Eenennaam
Journal:  J Immunother Cancer       Date:  2022-09       Impact factor: 12.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.